SET is also involved in the pathogenesis of Alzheimer’s disease; Chasseigneaux et al. reported an association between the cytoplasmic localization of SET and the reduction of methylated PP2A levels causing diminished PP2A activity and tau hyperphosphorylation (6). The gene discussed is PTPA; the disease is Alzheimer disease.